1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (3369)
  2. Meeting Abstract (1544)
  3. Review (164)
  4. Conference Paper (128)
  5. Book Section (124)
  6. Editorial (107)
  7. Research Letter (27)
  8. Miscellaneous (14)
  9. Book Whole (11)
  10. Guidelines (9)
  11. Correspondence (5)
Groups
  1. Center for Molecular Imaging and Biotechnology (5502)
  2. GSK Faculty (5304)
  3. Sloan Kettering Institute Faculty (3443)
  4. Tow Center for Developmental Oncology (TCDO) (2540)
  5. Department of Medicine (2432)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1823)

More Groups

People
  1. Richard O'Reilly (662)
  2. David Scheinberg (445)
  3. Ross Levine (426)
  4. Nai-Kong Cheung (419)
  5. Hedvig Hricak (387)
  6. Joan Massague (351)

More People

Years
  1. 2025 (1)
  2. 2024 (148)
  3. 2023 (248)
  4. 2022 (307)
  5. 2021 (289)
  6. 2020 (328)

More Years

Publications
  1. Blood (629)
  2. Cancer Research (188)
  3. Journal of Clinical Oncology (168)
  4. Journal of Nuclear Medicine (139)
  5. Biology of Blood and Marrow Transplantation (101)
  6. Proceedings of the National Academy of Sciences of the United States of America (95)

More Publications

Publishers
  1. American Society of Hematology (659)
  2. Nature Publishing Group (525)
  3. Elsevier Inc. (454)
  4. American Association for Cancer Research (366)
  5. Cell Press (354)
  6. Springer (202)

More Publishers

Results (5502)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies
    Journal Article

    Lee, C. Y.; Shah, M. K.; Hoyos, D.; Solovyov, A.; Douglas, M.; Taur, Y.; Maslak, P.; Babady, N. E.; Greenbaum, B.; Kamboj, M.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • KMT2A-MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8-year follow-up
    Journal Article

    Felix, C. A.; Slater, D. J.; Davenport, J. W.; Yu, X.; Gregory, B. D.; Li, M. M.; Rappaport, E. F.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Biomedical applications of lanthanide nanomaterials, for imaging, sensing and therapy
    Review

    Zhang, Q.; O’Brien, S.; Grimm, J.
    Nanotheranostics (2022)

    Fulltext@MSK | Save
  • Hyperpolarized micro-NMR platform for sensitive analysis of in vitro metabolic flux in living cells
    Journal Article

    Jeong, S.; Keshari, K. R.
    Methods in Molecular Biology (2022)

    Fulltext@MSK | Save
  • Radiopharmaceuticals in oncology
    Book Section

    Goos, J. A. C. M.; Keinänen, O.; Zeglis, B. M.; Lewis, J. S.
    In Kilbourn, M. R.; Scott, P. J. H. (Eds.) Handbook of Radiopharmaceuticals: Methodology and Applications. 2nd ed (2021)

    Fulltext@MSK | Save
  • Whole transcriptome analysis identifies distinct gene expression profiles between SF3B1(mut) and SF3B1(wt) myelodysplastic syndrome with ring sideroblasts
    Meeting Abstract

    Todisco, G.; Creignou, M.; Bernard, E.; Björklund, A. C.; Moura, P. L.; Jansson, M.; Chang, D.; Venckute, S.; Walldin, G.; Malcovati, L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • ERK2 substrate binding domains perform opposing roles in pathogenesis of a JAK2V617F-driven myeloproliferative neoplasm
    Meeting Abstract

    Truong, B.; Zhang, Y.; Fahl, S.; Qcai, K.; Martinez, E.; Al-Saleem, E.; Gong, Y.; Liebermann, D.; Soboloff, J.; Dunbrack, R.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Gilteritinib (GILT) monotherapy with addition of decitabine (DEC) in non-responders in older newly diagnosed (ND) FLT3 mutated acute myeloid leukemia (AML) patients having high and low variant allele frequency (VAF): A phase 2/1b sub-study of the Beat AML Master Trial
    Meeting Abstract

    Traer, E.; Huang, Y.; Mims, A. S.; Stein, E. M.; Baer, M. R.; Stock, W.; Kovacsovics, T.; Blum, W.; Arellano, M. L.; Schiller, G. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Isogenic MDS-RS patient-derived iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant hematopoietic stem/progenitor cells
    Meeting Abstract

    Asimomitis, G.; Deslauriers, A. G.; Kotini, A. G.; Bernard, E.; Esposito, D.; Olszewska, M.; Spyrou, N.; Ossa, J. A.; Mortera-Blanco, T.; Koche, R.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Ivosidenib (IVO) in combination with azacitidine (AZA) in newly diagnosed (ND) older patients with IDH1 R132-mutated acute myeloid leukemia (AML) induces high response rates: A phase 2 sub-study of the beat AML master trial
    Meeting Abstract

    Patel, P.; Ruppert, A. S.; Borate, U.; Stein, E. M.; Baer, M. R.; Stock, W.; Kovacsovics, T.; Blum, W.; Arellano, M. L.; Schiller, G. J.; more...
    Blood (2021)

    Fulltext@MSK | Save